Cell surface regulators of complement, 512 antigen, and CD59, in the rat eye and adnexal tissues

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 2, 1999, Pages 519-524

  Bardenstein, David S ^a   Cheyer, Chris ^a   Okada, Noriko ^a   Morgan, B Paul ^a   Medof, M Edward ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5I2 ANTIGEN; CD59 ANTIGEN; CELL PROTEIN; COMPLEMENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; COMPLEMENT DEPOSITION; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; EYE; EYELID; FEMALE; FIBROBLAST; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; ANTIGENS, SURFACE; EPITHELIUM; EYE; EYELIDS; FEMALE; IMMUNOENZYME TECHNIQUES; LACRIMAL APPARATUS; MEMBRANE GLYCOPROTEINS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT;

EID: 0032921402     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mondino BJ, Sumner H. Complement inhibitors in normal cornea and aqueous humor. Invest Ophthalmol Vis Sci. 1984;25:483-486.
2. Proia AD, Foulks GN, Sanfilippo FP. Ocular cicatricial pemphigoid with granular IgA and complement deposition. Arch Ophthalmol. 1985;103:1669-1672.
3. Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci. 1992;33:626-640.
4. Abbas AK, Lichtman AH, Pober JS. The complement system. In: Abbas AK, Lichtman AH, Pober JS, eds. Cellular and Molecular Immunology. 3rd ed. Philadelphia: WB Saunders; 1997:313-338.
5. Lass JH, Walter EI, Burns TE, et al. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci. 1990;31:1136-1148.
6. Bardenstein DS, Dietz Y, Lass JH, Medof ME. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva, cornea and lacrimal gland. Curr Eye Res. 1994;13:851-855.
7. Bora NS, Gobleman CL, Atkinson J, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci. 1993;34:3579-3584.
8. Takizawa H, Okada N, Okada H. Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol. 1994;152: 3032-3038.
9. Hughes TR, Piddlesden SJ, Williams JD, Harrison RH, Morgan BP. Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J. 1992;284:169-176.
10. Funabashi K, Okada N, Matsuo S, Yamamoto T, Morgan BP, Okada H. Tissue distribution of complement regulatory membrane proteins in rats. Immunology. 1994;81:444-451.
11. Spicer AP, Seldin MF, Gendler SJ. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J Immunol. 1995;155: 3079-3091.
12. Tsujimura A, Shida K, Kitamura M, et al. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J. 1998;330: 163-168.
13. Bora NS, Kabeer NH, Kim MC, Paryjas S, Atkinson JP, Kaplan HJ. Expression of the complement regulatory proteins in the normal and diseased (EAI) rat eye. In: Nussenblatt RB, Whitcup SM, Caspi RR Gery I, eds. Advances in Ocular Immunology: Proceedings of the 6th International Symposium on the Immunology and Immunopathology of the Eye, Bethesda, Maryland. New York: Elsevier; 1994:83-86.
14. Ballow M, Donshik PC, Rapacz P, Maenza R, Yamase H, Muncy L. Immune responses in monkeys to lenses from patients with contact lens-induced giant papillary conjunctivitis. CLAO J. 1989;15: 64-70.
15. Cheung N-K, Walter EI, Smith-Mensah WH, Ratnoff WD, Tykocinski ML, Medof ME. Decay-accelerating factor (DAF) protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest. 1988;81:1122-1128.
16. Goslings WRO, Blom DJR, DeWaard-Siebinga I, et al. Membrane-bound regulators of complement activation in uveal melanomas. Invest Ophthalmol Vis Sci. 1996;37:1884-1891.
17. Bardenstein DS, LaCross G, Medof E. Surface complement regulatory proteins on choroidal melanomas [ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1996;37(3):S246. Abstract nr 1123.